Maravai LifeSciences Stock Performance Shares of MRVI opened at $1.99 on Tuesday. The company has a quick ratio of 9.94, a current ratio of 10.74 and a debt-to-equity ratio of 0.89. The stock has ...

Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company ...

Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24 ...

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the ...

Specifically, Defendants failed to disclose to investors that: (1) Maravai lacked adequate internal controls over financial reporting related to revenue recognition; (2) as a result, Maravai ...

Maravai LifeSciences Holdings, Inc.'s stock has plummeted from $60 to $2.1 per share due to declining COVID vaccine-related revenues, but I am upgrading from a "Sell" to a "Hold" rating. The ...

San Francisco, California--(Newsfile Corp. - April 10, 2025) - Shares of Maravai LifeSciences Holdings (NASDAQ: MRVI) fell nearly 6% on March 19, 2025, following revelations that the company's ...

Stifel lowered the firm’s price target on Maravai Lifesciences (MRVI) to $5 from $10 and keeps a Buy rating on the shares.The firm notes Q4 revenues came up $1M light of the Street, while EBITDA ...

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ ...

Greetings. Welcome to Maravai LifeSciences fourth quarter 2024 results earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal ...

NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the ...

Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 118.5% in the fourth quarter, HoldingsChannel reports.